Form 4: CalciMedica Director Middleton Acquires Shares in Open Market Transaction

Fred A. Middleton, a director at CalciMedica, acquired 4,800 shares of common stock at $2.65 per share on December 6, 2024.

Summary

• Fred A. Middleton, a director of CalciMedica, purchased 4,800 shares of common stock at a price of $2.65 per share on December 6, 2024.
• Following this transaction, Mr. Middleton directly owns 36,514 shares.
• Mr. Middleton also has indirect beneficial ownership of a significant number of shares through various Sanderling Venture Partners entities and Golden Triangle Ventures, LLC.
• These indirect holdings include 814,300 shares through Sanderling Venture Partners VI Co-Investment Fund, L.P., 946,744 shares through Sanderling Venture Partners VI, LP, and other holdings through related entities.
• Additionally, he indirectly holds shares through Sanderling Ventures VII, L.P. and related entities, as well as 8,176 shares through Golden Triangle Ventures, LLC.

Sentiment

Score: 6

Explanation: The document reflects a routine insider transaction. While the purchase is a positive signal, it's not a major event that would significantly shift sentiment.

Positives

• The director's purchase of shares could be seen as a positive signal of confidence in the company's future prospects.
• The purchase increases the director's direct stake in the company.

Risks

• The document primarily reflects a transaction by an insider and does not indicate any specific risks to the company.

Industry Context

This is a standard SEC Form 4 filing, which is common for corporate insiders who trade in their company's stock. It provides transparency into insider transactions.

Comparison to Industry Standards

• Form 4 filings are a standard practice for publicly traded companies in the United States.
• The transaction is typical of insider trading activity and is consistent with regulatory requirements.
• The level of detail provided in the filing is consistent with SEC guidelines.

Stakeholder Impact

• The transaction may have a minor positive impact on shareholder sentiment due to the director's purchase.

Key Dates

Keywords

CalciMedica, insider trading, beneficial ownership, Form 4, stock purchase, Fred A. Middleton, Sanderling Ventures, Golden Triangle Ventures